Results 111 to 120 of about 148,322 (271)
Health Care Opinion Leaders' Views on Payment System Reform [PDF]
, 2008 Presents results of a survey of healthcare experts on the adequacy of the current fee-for-service payment system, reform options, strategies to improve efficiency and effectiveness, and changes to Medicare.
Karen Davis +2 more
core
Do Sustainability Committees Mitigate or Exacerbate ESG Decoupling?
Business Strategy and the Environment, EarlyView.ABSTRACT This study investigates the impact of sustainability committees (SCs) on environmental, social, and governance (ESG) decoupling in US publicly listed firms. In particular, it examines their influence on overall and dimension‐specific (E, S, G) ESG decoupling and distinguishes their effects on internal versus external ESG actions.
Weite Qiu +4 more
wiley +1 more source
A Fork in the Road: Obama, McCain, and Health Care [PDF]
, 2008 Healthcare reform will be one of the top issues of the 2008 presidential election. In the face of widespread public demand for changes in the U.S. health care system, both Barack Obama and John McCain have offered detailed proposals for reform.
Michael D. Tanner
core
Business Strategy and the Environment, EarlyView.ABSTRACT Focusing on firm‐size heterogeneity, this study examines how institutional reform reshapes the effects of environmental, social, and governance (ESG) disclosure on firm value. Using 2019–2023 panel data on 1427 Japanese listed firms (before and after the 2022 Tokyo Stock Exchange reorganization and Corporate Governance Code revision), this ...
Akio Nakashima, Kimitaka Nishitani
wiley +1 more source
The Impact of Accountable Care: Interactions between patients and payers – Where do pharmacists lie? [PDF]
, 2017 Introduction: Over the past several years, patient outcomes became the focus of health care. With increased accountability, pharmacy education must transform the next generation of health care providers according to the new 2016 Accreditation Council for
Stone, Danielle
core +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo +8 more
wiley +1 more source
Annals of Mechnikov's Institute, 2019 Introduction. Nowadays there is no ideal healthcare system for medical and pharmaceutical provision for privileged categories of citizens in the world. Healthcare systems for medical and pharmaceutical provision for different categories of population of ...
V Shapovalov +4 more
doaj
Clinical Pharmacology &Therapeutics, EarlyView.Fentanyl, hydromorphone, and oxycodone are metabolized by cytochrome P450 3A4 (CYP3A4). Co‐administration with CYP3A4‐inhibiting macrolides (clarithromycin or erythromycin) may increase opioid concentrations and overdose risk, but the clinical impact of these interactions is unknown.
Tony Antoniou +7 more
wiley +1 more source
The other health care system in Germany: care for people without health insurance
BMC Health Services ResearchBackground A large number of people in Germany have no health insurance. Their access to the official healthcare system is significantly more difficult or impossible.
Matthias Zimmer
doaj +1 more source
Paying for "End-of-Life" Drugs in Australia, Germany, and the United Kingdom: Balancing Policy, Pragmatism, and Societal Values [PDF]
, 2012 Analyzes British, Australian, and German health systems' policies on covering expensive end-of-life drugs while maintaining equity and efficiency, such as requiring evidence of comparative clinical and cost-effectiveness.
Andreas Gerber +2 more
core